PANCREATIC LIPASE INHIBITOR

/ Uncategorized / By
  1. The lipase inhibitor tetrahydrolipstatin binds covalently to the putative active site serine of pancreatic lipase
  2. A new pancreatic lipase inhibitor isolated from the roots of Actinidia arguta
  3. A new pancreatic lipase inhibitor from Broussonetia kanzinoki
  4. Quercetin is a promising pancreatic lipase inhibitor in reducing fat absorption in vivo
  5. Weight Gain Reduction in Mice Fed Panax ginseng Saponin, a Pancreatic Lipase Inhibitor
  6. Anti-obesity effects of galangin, a pancreatic lipase inhibitor in cafeteria diet fed female rats
  7. Inhibition of pancreatic lipase in vitro by the covalent inhibitor tetrahydrolipstatin
  8. Cetilistat (ATL-962), a novel pancreatic lipase inhibitor, ameliorates body weight gain and improves lipid profiles in rats
  9. Anti-obesity activity of hen egg anti-lipase immunoglobulin yolk, a novel pancreatic lipase inhibitor
  10. Antiobesity action of ɛ-polylysine, a potent inhibitor of pancreatic lipase
  11. Relationship between improved postprandial lipemia and low-density lipoprotein metabolism during treatment with tetrahydrolipstatin, a pancreatic lipase inhibitor
  12. High-Resolution Bioassay Profiling with Complemented Sensitivity and Resolution for Pancreatic Lipase Inhibitor Screening
  13. Proteinaceous pancreatic lipase inhibitor from the seed of Litchi chinensis
  14. Lipstatin, an inhibitor of pancreatic lipase, produced by Streptomyces toxytricini I. Producing organism, fermentation, isolation and biological activity
  15. Lipstatin, an inhibitor of pancreatic lipase, produced by Streptomyces toxytricini II. Chemistry and structure elucidation
  16. Elucidating the Biosynthetic Pathway for Vibralactone: A Pancreatic Lipase Inhibitor with a Fused Bicyclic β‐Lactone
  17. Kojic acid repurposing as a pancreatic lipase inhibitor and the optimization of its production from a local Aspergillus oryzae soil isolate
  18. Development of QSAR model using machine learning and molecular docking study of polyphenol derivatives against obesity as pancreatic lipase inhibitor
  19. Studies on the antiobesity activity of tetrahydrolipstatin, a potent and selective inhibitor of pancreatic lipase.
  20. Cassia grandis Lf nanodispersion is a hypoglycemic product with a potent α-glucosidase and pancreatic lipase inhibitor effect
  21. … aldol-lactonization (TMAL) reaction: A concise and highly diastereoselective route to β-lactones applied to the total synthesis of the potent pancreatic lipase inhibitor …
  22. In-vitro functional efficacy of extracts from Phyllanthus emblica, Eucalyptus globulus, Tinospora cordifolia as pancreatic lipase inhibitor and source of anti-oxidant in …
  23. Phytochemical and Biological Profile of Moricandia arvensis (L.) DC.: An Inhibitor of Pancreatic Lipase
  24. Theophylline extracted from fu brick tea affects the metabolism of preadipocytes and body fat in mice as a pancreatic lipase inhibitor
  25. The community management of chylous fistula using a pancreatic lipase inhibitor (orlistat)
  26. Proteinous pancreatic lipase inhibitor is responsible for the antiobesity effect of young barley (Hordeum vulgare L.) leaf extract
  27. Peptide inhibitor of pancreatic lipase selected by phage display using different elution strategies
  28. Synthesis and Study of a Lipophilic α-Keto Amide Inhibitor of Pancreatic Lipase
  29. Utilization of Agro-Waste of Piper longum for a Potential Pancreatic Lipase Inhibitor
  30. 5-Hydroxy-7-(4′-hydroxy-3′-methoxyphenyl)-1-phenyl-3-heptanone: a pancreatic lipase inhibitor isolated from Alpinia officinarum
  31. Operon for biosynthesis of lipstatin, the beta-lactone inhibitor of human pancreatic lipase
  32. Saponin isolates from cucumber (Cucumis sativus L.) fruit mesocarp and their activity as pancreatic lipase inhibitor
  33. Functional Imaging and Inhibitor Screening of Human Pancreatic Lipase by a Resorufin-Based Fluorescent Probe
  34. Large spectral changes accompany the conformational transition of human pancreatic lipase induced by acylation with the inhibitor tetrahydrolipstatin
  35. Endophytic actinobacteria isolated from ginger (Zingiber officinale) and its potential as a pancreatic lipase inhibitor and its toxicity
  36. The activity of flavonoid isolates from Papaya (Carica papaya L.) seed as pancreatic lipase inhibitor
  37. Surface display of pancreatic lipase inhibitor peptides by engineered Saccharomyces boulardii: Potential as an anti-obesity probiotic
  38. Anti-obesity effect of ethanolic extract of jasmine flowers (jasminumsambac (l) Ait) in high-fat diet-induced mice: potent inhibitor of pancreatic lipase enzyme
  39. Pancreatic lipase inhibitory activity of phenolic inhibitor from endophytic Diaporthe arengae
  40. FTIR analysis of phenolic compound as pancreatic lipase inhibitor from inoculated Aquilaria malaccensis
  41. … and biological characterization of dry outer scales extract from Tropea red onion (Allium cepa L. var. Tropea)–A promising inhibitor of pancreatic lipase
  42. Endophytic pestalotiopsis species from Andaman Islands: A potential pancreatic lipase inhibitor
  43. Purple tea: chemical characterization and evaluation as inhibitor of pancreatic lipase and fat digestion in mice
  44. The lipase C-terminal domain: A novel unusual inhibitor of pancreatic lipase activity
  45. Saponin from purple eggplant (Solanum melongena L.) and their activity as pancreatic lipase inhibitor
  46. Discovery of a novel synthetic thiazole-benzimidazole conjugate that acts as a potent pancreatic lipase inhibitor using in silico and in vitro approaches
  47. A rationally engineered specific near-infrared fluorogenic substrate of human pancreatic lipase for functional imaging and inhibitor screening
  48. (E)-4-aminostyryl acetate a novel pancreatic lipase inhibitor produced by a Streptomyces sp. MTCC 5219.
  49. Diversity of endophytic actinobacteria isolated from medicinal plants and their potency as pancreatic lipase inhibitor
  50. In vitro and in silico analysis of cucumber (Cucumis sativus L.) mesocarp powder as pancreatic lipase and α-amylase inhibitor
  51. A new pancreatic lipase inhibitor produced by a Streptomyces sp. MTCC 5219
  52. Effect of pancreatic lipase inhibitor and sorbent of lipids on cholesterolaemia and faecal output of fat in rats
  53. In vitro and In silico Analysis of Pomegranate (Punica granatum L.) Fruit Powder as Pancreatic Lipase and α-Amylase Inhibitor
  54. In silico studies on pancreatic lipase and cholesterol esterase inhibitor 2, 6-di-tert-butyl phenol: A novel molecule for Antiobesity
  55. HPLC based fractionation and microtiter plate based bioactivity profiling of Ocimum sanctum Linn. leaves for potential pancreatic lipase inhibitor (s)
  56. IN SILICO DOCKING OF EPICATECHIN, CORILAGIN AND QUERCETIN AS POTENTIAL PANCREATIC LIPASE INHIBITOR
  57. In Silico Analysis of Glucosinolates as Pancreatic Lipase Inhibitor to Develop Anti-obesity Drug
  58. Effect of pancreatic lipase inhibitor on the exocrine part of the pancreas in adult male albino rats: a histological and morphometric study
  59. Effect of diacylglycerol lipase inhibitor RHC 80267 on pancreatic mouse islet metabolism and insulin secretion
  60. In Silico Analysis of Saponin Isolates from Mesocarp of Cucumber (Cucumic sativus L.) and Purple Eggplant (Solanum melongena L.) as Pancreatic Lipase Inhibitor
  61. Pancreatic lipase inhibitor immunoglobulin yolk from hen egg to prevent obesity
  62. Concise, stereoselective routes to beta-lactones: Application to the synthesis of the potent pancreatic lipase inhibitor,(-)-panclicin D
  63. Biologically active additive-inhibitor of pancreatic lipase.
  64. FOXTAIL MILLET (SETARIA ITALICA) EXTRACT AS PANCREATIC LIPASE INHIBITOR AND POTENTIAL NATURAL ANTI-OBESITY DRUG
  65. OA01. 38. Anti-obesity activity of Zizyphyus mauritiana lam: a potent pancreatic lipase inhibitor
  66. Plasma levels of pancreatic secretory trypsin inhibitor in relation to amylase and lipase in patients with acute and chronic renal failure
  67. Berry polyphenols inhibit pancreatic lipase activity in vitro
  68. White and green tea polyphenols inhibit pancreatic lipase in vitro
  69. Caffeoylquinic acids competitively inhibit pancreatic lipase through binding to the catalytic triad
  70. Extracts of edible plants inhibit pancreatic lipase, cholesterol esterase and cholesterol micellization, and bind bile acids
  71. Viburnum opulus L. Juice Phenolics Inhibit Mouse 3T3-L1 Cells Adipogenesis and Pancreatic Lipase Activity
  72. Walnut polyphenols inhibit pancreatic lipase activity in vitro and have hypolipidemic effect on high-fat diet-induced obese mice
  73. Testing edible mushrooms to inhibit the pancreatic lipase activity by an in vitro digestion model
  74. Milling and Processing of Wheat and other Cereals Affect Their Capacity to Inhibit Pancreatic Lipase in Vitro
  75. Proanthocyanidin Oligomers Isolated from Salacia reticulata leaves potently Inhibit Pancreatic Lipase Activity
  76. Indian medicinal plants known to contain intestinal glucosidase inhibitors also inhibit pancreatic lipase activity—An ideal situation for obesity control by herbal drugs
  77. Hydroxylated polymethoxyflavones reduce the activity of pancreatic lipase, inhibit adipogenesis and enhance lipolysis in 3T3-L1 mouse embryonic fibroblast …
  78. Chitosan does not inhibit enzymatic action of human pancreatic lipase in Langmuir monolayers of 1, 2-didecanoyl-glycerol (DDG)
  79. Rhei rhizoma and chunghyuldan inhibit pancreatic lipase
  80. … in selected cultivars of Prunus persica L. and their ability to in vitro inhibit lipoxygenase, cholinoesterase, α-amylase, α-glucosidase and pancreatic lipase
  81. Viburnum opulus L. Juice Phenolics Inhibit Mouse 3T3-L1 Cells Adipogenesis and Pancreatic Lipase Activity
  82. Development of fermented vegetables in their ability to inhibit pancreatic lipase as antidyslipidemic agent
  83. Inhibitors of diacylglycerol lipase and diacylglycerol kinase inhibit carbamylcholine-stimulated responses in guinea pig pancreatic minilobules
  84. Screening of selected food and medicinal plant extracts for pancreatic lipase inhibition
  85. Pancreatic lipase inhibition activity of trilactone terpenes of Ginkgo biloba
  86. Mode of pancreatic lipase inhibition activity in vitro by some flavonoids and non-flavonoid polyphenols
  87. Biological activity of alginate and its effect on pancreatic lipase inhibition as a potential treatment for obesity
  88. Pancreatic Lipase Inhibition by C-Glycosidic Flavones Isolated from Eremochloa ophiuroides
  89. Studies on the detergent inhibition of pancreatic lipase activity.
  90. Antiobesity properties of two African plants (Afromomum meleguetta and Spilanthes acmella) by pancreatic lipase inhibition
  91. Optimization of pancreatic lipase inhibition by Cudrania tricuspidata fruits using response surface methodology
  92. Screening of the anthocyanin profile and in vitro pancreatic lipase inhibition by anthocyanin‐containing extracts of fruits, vegetables, legumes and cereals
  93. Inhibition of pancreatic lipase by phenolic acids-examination in vitro
  94. Oligomeric procyanidins in apple polyphenol are main active components for inhibition of pancreatic lipase and triglyceride absorption
  95. Pancreatic lipase inhibition of strictinin isolated from Pu’er tea (Cammelia sinensis) and its anti-obesity effects in C57BL6 mice
  96. Solvents effect on phenolics, iridoids, antioxidant activity, antibacterial activity, and pancreatic lipase inhibition activity of noni (Morinda citrifolia L.) fruit extract
  97. Inhibition of hormone sensitive lipase and pancreatic lipase by Rosmarinus officinalis extract and selected phenolic constituents
  98. Synthesis and evaluation of α-glucosidase and pancreatic lipase inhibition by quinazolinone-coumarin hybrids
  99. In vitro inhibition of pancreatic lipase by polyphenols: A kinetic, fluorescence spectroscopy and molecular docking study
  100. Determination of the kinetic properties of platycodin D for the inhibition of pancreatic lipase using a 1, 2-diglyceride-based colorimetric assay
  101. High‐theabrownins instant dark tea product by Aspergillus niger via submerged fermentation: α‐glucosidase and pancreatic lipase inhibition and antioxidant activity
  102. Study of Antiobesity Effect through Inhibition of Pancreatic Lipase Activity of Diospyros kaki Fruit and Citrus unshiu Peel
  103. Medicinal plants traditionally used for treatment of obesity and diabetes mellitus–screening for pancreatic lipase and α‐Amylase inhibition
  104. Inhibition of pancreatic lipase by black tea theaflavins: Comparative enzymology and in silico modeling studies
  105. Antiobesity drug-likeness properties and pancreatic lipase inhibition of a novel low molecular weight lutein oxidized product, LOP6
  106. Inhibition of pancreatic lipase by environmental xenoestrogens
  107. Inhibition of pancreatic lipase by water extracts of some herbal mixtures
  108. Biflavones from Ginkgo biloba as novel pancreatic lipase inhibitors: Inhibition potentials and mechanism
  109. Metabolic diversity and in vitro pancreatic lipase inhibition activity of some varieties of Mangifera indica L. fruits
  110. Inhibition of human pancreatic lipase-colipase activity by mixed bile salt-phospholipid micelles
  111. Pancreatic lipase inhibition by edible plants used in three middle east countries: A mini-review
  112. Inhibition of pancreatic lipase by the constituents in St. John’s Wort: In vitro and in silico investigations
  113. Inhibition of pancreatic lipase, α-glucosidase, α-amylase, and hypolipidemic effects of the total flavonoids from Nelumbo nucifera leaves
  114. Inhibition of pancreatic lipase and amylase by extracts of different spices and plants
  115. Inhibition of human pancreatic lipase by tetrahydrolipstatin: further kinetic studies showing its reversibility
  116. In vitro anti‐obesity activity by pancreatic lipase inhibition ‐ Simple HPLC approach using EVOO as natural substrate
  117. Preclinical and clinical effects of Coleus forskohlii, Salacia reticulata and Sesamum indicum modifying pancreatic lipase inhibition in vitro and reducing total body fat
  118. Inhibition of key enzymes linked to obesity by preparations from Mediterranean dietary plants: effects on α-amylase and pancreatic lipase activities
  119. Coffee simulated inhibition of pancreatic lipase and antioxidant activities: Effect of milk and decaffeination
  120. Covalent immobilization of porcine pancreatic lipase on carboxyl-activated magnetic nanoparticles: characterization and application for enzymatic inhibition assays
  121. Investigation of the kinetic properties of Phyllanthus chamaepeuce Ridl. extracts for the inhibition of pancreatic lipase activity
  122. Inhibition of the in vitro activities of α‐amylase, α‐glucosidase and pancreatic lipase by yellow field pea (Pisum sativum L.) protein hydrolysates
  123. Study of pancreatic lipase inhibition kinetics and LC–QTOF–MS‐based identification of bioactive constituents of Momordica charantia fruits
  124. Inhibitory effect of astaxanthin on pancreatic lipase with inhibition kinetics integrating molecular docking simulation
  125. Inhibition of pancreatic lipase by berberine and dihydroberberine: an investigation by docking simulation and experimental validation
  126. Effects of different particle-sized insoluble dietary fibre from citrus peel on adsorption and activity inhibition of pancreatic lipase
  127. Inhibition of pancreatic lipase B activity by taurodeoxycholate and its reversal by colipase.
  128. Fermented green tea extract exhibits hypolipidaemic effects through the inhibition of pancreatic lipase and promotion of energy expenditure
  129. Mechanistic insights into the inhibition of pancreatic lipase by apigenin: Inhibitory interaction, conformational change and molecular docking studies
  130. Cellular antioxidant activity and in vitro inhibition of α-glucosidase, α-amylase and pancreatic lipase of oregano polyphenols under simulated gastrointestinal digestion
  131. Inhibition of pancreatic lipase by extracts of Baccharis trimera (Less.) DC., Asteraceae: evaluation of antinutrients and effect on glycosidases
  132. Nanoemulsified orlistat-embedded multi-unit pellet system (MUPS) with improved dissolution and pancreatic lipase inhibition
  133. Anti-Obesity Effect of DKB-117 through the Inhibition of Pancreatic Lipase and α-Amylase Activity
  134. Inhibition of α-Glucosidase and Pancreatic Lipase Properties of Mitragyna speciosa (Korth.) Havil. (Kratom) Leaves
  135. Inhibition of Pancreatic Lipase and Triacylglycerol Intestinal Absorption by a Pinhão Coat (Araucaria angustifolia) Extract Rich in Condensed Tannin
  136. Kinetic behaviour of pancreatic lipase inhibition by ultrasonicated A. Malaccensis and A. Subintegra leaves of different particle sizes
  137. Inhibition of pancreatic lipase by tetracyclines
  138. Biological activities of camelina and sophia seeds phenolics: Inhibition of LDL oxidation, DNA damage, and pancreatic lipase and α‐glucosidase activities
  139. Camellia nitidissima Chi leaf as pancreatic lipase inhibitors: Inhibition potentials and mechanism
  140. Inhibition of the in vitro Activities of α-Amylase and Pancreatic Lipase by Aqueous Extracts of Amaranthus viridis, Solanum macrocarpon and Telfairia …
  141. Design, synthesis, spectroscopic characterizations, in vitro pancreatic lipase as well as tyrosinase inhibition evaluations and in silico analysis of novel aryl sulfonate …
  142. Pancreatic Lipase Inhibition Activity in Lipid Absorption Using Traditional Plants: A Systematic Review and Meta-Analysis
  143. Porcine pancreatic lipase inhibitory agent isolated from medicinal herb and inhibition kinetics of extracts from Eleusine indica (L.) Gaertner
  144. Araçá (Psidium cattleianum Sabine): bioactive compounds, antioxidant activity and pancreatic lipase inhibition
  145. Pancreatic lipase inhibition by papaverine: investigation by simulated molecular docking and subsequent in vitro evaluation
  146. Prominent pancreatic lipase inhibition and free radical scavenging activity of a myristica fragrans ethanolic extract in vitro. Potential role in obesity treatment
  147. Saponin-enriched sea cucumber extracts exhibit an antiobesity effect through inhibition of pancreatic lipase activity and upregulation of LXR-β signaling
  148. … by soluble dietary fibre from micronized and non-micronized powders of lotus root nodes as revealed by their adsorption and activity inhibition of pancreatic lipase
  149. Inhibition of α-amylase, α-glucosidase and pancreatic lipase by phenolic compounds of Rumex maderensis (Madeira sorrel). Influence of simulated gastrointestinal …
  150. Extraction optimisation, antioxidant activity and inhibition on α‐amylase and pancreatic lipase of polyphenols from the seeds of Syzygium cumini
  151. … Lycium ruthenicum Murray in High-Fat Diet-Induced Obese Mice Are Related to the Regulation of Intestinal Microbiota and Inhibition of Pancreatic Lipase …
  152. Inhibition of phospholipase A1, lipase and galactolipase activities of pancreatic lipase-related protein 2 by methyl arachidonyl fluorophosphonate (MAFP)
  153. Kinetic behaviour of pancreatic lipase inhibition by wine
  154. Chemical profile, in vitro antioxidant, pancreatic lipase, and alpha-amylase inhibition assays of the aqueous extract of Elettaria cardamomum L. fruits
  155. The inhibition mechanisms of pancreatic lipase by apigenin and its anti-obesity mechanisms revealed by using network pharmacology
  156. Hypolipidemic mechanism of gypenosides via inhibition of pancreatic lipase and reduction in cholesterol micellar solubility
  157. ABTS On-Line Antioxidant, α-Amylase, α-Glucosidase, Pancreatic Lipase, Acetyl- and Butyrylcholinesterase Inhibition Activity of Chaenomeles Fruits Determined by …
  158. A 2-methyleneoxetane analog of orlistat demonstrating inhibition of porcine pancreatic lipase
  159. Inhibition of pancreatic lipase by Hymenolepis diminuta
  160. Inhibition of pancreatic lipase by ovalbumin and β-lactoglobulin A at the air/water interface
  161. A Study on Ethanolic Extract of Dalbergia sissoo roxb. Leaves for Pancreatic Lipase Inhibition.
  162. Inhibition of pancreatic lipase by mixed micelles of diethyl p-nitrophenyl phosphate and bile salts
  163. Plumbagin exerts antiobesity effects through inhibition of pancreatic lipase and adipocyte differentiation
  164. Differential inhibition of HMG-CoA synthase and pancreatic lipase by the specific chiral isomers of β-lactone DU-6622
  165. … fistula Leaves; UHPLC-QTOF-MS/MS based metabolite profiling and molecular docking insights to explore bioactives role towards inhibition of pancreatic lipase
  166. Lactobacillus-fermentation enhances nutritional value and improves the inhibition on pancreatic lipase and oral pathogens of edible red seaweed Bangia …
  167. The Effect of Divalent Metals on the Inhibition of Pancreatic Lipase by Chlortetra-cycline.
  168. Inhibition of pancreatic lipase by poloxamer 407 may provide an adjunct treatment strategy for weight loss
  169. 3D Printed Polylactic Acid (PLA) Well Plates for Enzyme Inhibition Studies: The Case of Pancreatic Lipase
  170. Inhibition of glutathione and s-allyl glutathione on pancreatic lipase: Analysis through in vitro kinetics, fluorescence spectroscopy and in silico docking
  171. Stem bark extracts of Endopleura uchi (Huber) Cuatrec: Inhibition of pancreatic lipase and antioxidant activity
  172. Molecular structures, chemical descriptors, and pancreatic lipase (1LPB) inhibition by natural products: a DFT investigation and molecular docking prediction
  173. Screening, identification and activity evaluation of pancreatic lipase inhibition in Prunella vulgaris
  174. Inhibition of α-amylase, α-glucosidase and pancreatic lipase activities in vitro by sacha inchi (Plukenetia volubilis L.) protein hydrolysates and their fractionated …
  175. Irreversible inhibition of pancreatic lipase by bis‐p‐nitrophenyl methylphosphonate
  176. Evaluation of Indonesian Anti-obesity Traditional Medicinal Plants: A Systematic Review and Meta-analysis on Pancreatic Lipase Inhibition Activity
  177. Anti-obesity activity of polyherbal formulation Divya-Medohar-Vati by inhibition of pancreatic lipase activity and triglyceride translocation through enterocytes
  178. Synthesis and evaluation of benzylisoquinoline derivatives for their inhibition on pancreatic lipase and preadipocyte proliferation
  179. … of Izmir Gulf: Cystoseira barbata, Cystoseira compressa and Cystoseira crinita species have high α-glucosidase and Moderate Pancreatic Lipase Inhibition …
  180. The mechanisms of action and inhibition of pancreatic lipase and acetylcholinesterase: a comparative modeling study
  181. Kinetic Studies on Pancreatic Lipase Activity in Micellar Systems. I. Inhibition by Sodium Deoxycholate Micelles
  182. Effect of substrate concentration and reaction time of Aquilaria subintegra leaves extract on inhibition of pancreatic lipase
  183. Pancreatic lipase activation, inhibition, and relationship to peroxide oxidation of lipids
  184. PolyPhenolic rich fraction of Terminalia paniculata attenuates obesity through inhibition of pancreatic amylase, lipase and 3T3-L1 adipocyte differentiation
  185. Inhibition of pancreatic lipase by flavonoids: Relevance of the C2= C3 double bond and C-ring planarity
  186. Evaluation of pancreatic lipase inhibition activity and antioxidant potential of Vinca rosea leaves
  187. Proeminent Pancreatic Lipase Inhibition and Free Radical Scavenging Activity of a Myristica fragrans Ethanolic Extract in vitro. Potential Role in Obesity Treatment.
  188. Inhibition of pancreatic lipase by gallic acid and quercetin equivalent in ultrasonicated Malaysian grown Aquilaria spp. leaves of different particle size
  189. The potency of chlorogenic acid extract from green coffee beans on inhibition pancreatic lipase activity
  190. Inhibition of Pancreatic Lipase and Characterization by Extracts From Fruit Pomaces Cultivars Grown in Brazilian Semiarid
  191. Chemogenic Synthesis of Chromium Oxide Nanoparticles using Sol-Gel Method and its Potential on Pancreatic Lipase Inhibition
  192. Total Antioxidant Activity and Enzymatic Inhibition against Alpha-Amylase, Alpha-Glucosidase and Pancreatic Lipase of Irradiated Archidendron bubalinum
  193. Pharmacophore Mapping of Natural Products for Pancreatic Lipase Inhibition
  194. In vitro pancreatic lipase inhibition potential of Panchavalkala Aqueous and Ethanolic bark extracts.
  195. The inhibition of pancreatic lipase by ursolic acid from natural source
  196. Evaluation of the anti-obesity potential of polyphenols through pancreatic lipase inhibition
  197. A Study on Ethanolic Extract of Dalbergia sissoo roxb. Leaves for Pancreatic Lipase Inhibition.
  198. Pancreatic lipase inhibition by papaverine: investigation by simulated molecular docking and subsequent in vitro evaluation
  199. In-vitro inhibition of Malaysian grown Aquilaria Spp. extracts and kinetic on pancreatic lipase
  200. Inhibition of Pancreatic Lipase by Grape Seed and Tea Extracts and Their Primary Catechins in vitro
  201. INHIBITION OF PANCREATIC LIPASE ACTIVITY BY PLUMERIA PUDICA LEAVES; AN APPROACH TO THE TREATMENT OF OBESITY
  202. Inhibition of Pancreatic Lipase and the Renin Angiotensin System Synergistically Decreases Body Fat
  203. … performed studies on their potency as antiobesity. The aim of this research was to investigate the potency of Z. cassumunar rhizome, G. ulmifolia, and M. paniculata leaf extracts as antiobesity agent based on in vitro inhibition activity of the extracts on pancreatic lipase activity. In this research, water content determination, phytochemical assay, toxicity assay and in vitro assay of inhibition activity on pancreatic lipase were performed toward …
  204. From Lipase Elevation to Diabetes–Pancreatic Involvement during Immune Checkpoint Inhibition
  205. Selectivity of inhibition of pancreatic enzyme secretion after lipase administration into the duodenum
  206. Inhibition of Mono‐Acyl‐Glycerol Lipase by JZL‐184 Results in Glucolipotoxicity in Pancreatic β‐Cells
  207. Initial studies in humans with the novel gastrointestinal lipase inhibitor Ro 18–0647 (tetrahydrolipstatin)
  208. Orlistat, a new lipase inhibitor for the management of obesity
  209. Cetilistat, a new lipase inhibitor for the treatment of obesity.
  210. Mode of action of tetrahydrolipstatin: a derivative of the naturally occurring lipase inhibitor lipstatin
  211. A model for interfacial activation in lipases from the structure of a fungal lipase-inhibitor complex
  212. Anti-obesity effects in rodents of dietary teasaponin, a lipase inhibitor
  213. CAY10499, a novel monoglyceride lipase inhibitor evidenced by an expeditious MGL assay
  214. Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: a 1-y study
  215. Review of limited systemic absorption of orlistat, a lipase inhibitor, in healthy human volunteers
  216. The monoacylglycerol lipase inhibitor JZL184 suppresses inflammatory pain in the mouse carrageenan model
  217. One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor
  218. Licochalcone A: a lipase inhibitor from the roots of Glycyrrhiza uralensis
  219. Acute oxalate nephropathy associated with orlistat, a gastrointestinal lipase inhibitor
  220. In vivo characterization of the highly selective monoacylglycerol lipase inhibitor KML29: antinociceptive activity without cannabimimetic side effects
  221. Monoacylglycerol lipase inhibitor JZL184 reduces neuroinflammatory response in APdE9 mice and in adult mouse glial cells
  222. Anti-obesity effects of lipase inhibitor CT-II, an extract from edible herbs, Nomame Herba, on rats fed a high-fat diet
  223. Vibralactone:  A Lipase Inhibitor with an Unusual Fused β-Lactone Produced by Cultures of the Basidiomycete Boreostereum vibrans
  224. Current trends and future prospects of lipstatin: a lipase inhibitor and pro-drug for obesity
  225. Long‐term systemic exposure of orlistat, a lipase inhibitor, and its metabolites in obese patients
  226. Controlling drug release by introducing lipase inhibitor within a lipid formulation
  227. The lipoprotein lipase inhibitor ANGPTL3 is negatively regulated by thyroid hormone
  228. Repeated low-dose administration of the monoacylglycerol lipase inhibitor JZL184 retains cannabinoid receptor type 1–mediated antinociceptive and gastroprotective …
  229. Lipase Inhibitor from Fruits of Solanum stramonifolium Jacq.
  230. Monoacylglycerol lipase inhibitor JZL184 regulates apoptosis and migration of colorectal cancer cells
  231. Acteoside: a lipase inhibitor from the Chinese tea Ligustrum purpurascens kudingcha
  232. Targeting lipid metabolism by the lipoprotein lipase inhibitor orlistat results in apoptosis of B-cell chronic lymphocytic leukemia cells
  233. The monoacylglycerol lipase inhibitor JZL184 is neuroprotective and alters glial cell phenotype in the chronic MPTP mouse model
  234. The effect of the gastrointestinal lipase inhibitor, orlistat, on serum lipids and lipoproteins in patients with primary hyperlipidaemia
  235. Effects of ebelactone B, a lipase inhibitor, on intestinal fat absorption in the rat
  236. Reduction of dietary fat absorption by the novel gastrointestinal lipase inhibitor cetilistat in healthy volunteers
  237. Effects of tetrahydrolipstatin, a lipase inhibitor, on absorption of fat from the intestine of the rat
  238. The monoacylglycerol lipase inhibitor JZL 184 attenuates LPS‐induced increases in cytokine expression in the rat frontal cortex and plasma: differential mechanisms …
  239. Lipase immobilization on multi-walled carbon nanotubes used as a target fishing tool and followed by molecular docking technique to analyze lipase inhibitor from …
  240. The selective monoacylglycerol lipase inhibitor MJN110 produces opioid-sparing effects in a mouse neuropathic pain model
  241. Effects of monoacylglycerol lipase inhibitor URB602 on lung ischemia-reperfusion injury in mice
  242. Fat malabsorption induced by gastrointestinal lipase inhibitor leads to an increase in urinary oxalate excretion
  243. Ketamine and MAG lipase inhibitor-dependent reversal of evolving depressive-like behavior during forced abstinence from alcohol drinking
  244. Role of lipase in the regulation of postprandial gastric acid secretion and emptying of fat in humans: a study with orlistat, a highly specific lipase inhibitor
  245. Intsia palembanica wood extracts and its isolated compounds as Propionibacterium acnes lipase inhibitor
  246. Monoacylglycerol lipase inhibitor JZL184 improves behavior and neural properties in Ts65Dn mice, a model of down syndrome
  247. Modulating the release of pharmaceuticals from lipid cubic phases using a lipase inhibitor
  248. Effects of the lipase inhibitor orlistat on intake and preference for dietary fat in rats
  249. Spinal administration of the monoacylglycerol lipase inhibitor JZL 184 produces robust inhibitory effects on nociceptive processing and the development of central …
  250. The novel monoacylglycerol lipase inhibitor MJN110 suppresses neuroinflammation, normalizes synaptic composition and improves behavioral performance …
  251. Increased lipase inhibition in uremia: identification of pre-β-HDL as a major inhibitor in normal and uremic plasma
  252. The Monoacylglycerol Lipase Inhibitor JZL184 Inhibits Lung Cancer Cell Invasion and Metastasis via the CB1 Cannabinoid Receptor
  253. Blockade of 2-arachidonoylglycerol hydrolysis by selective monoacylglycerol lipase inhibitor 4-nitrophenyl 4-(dibenzo [d][1, 3] dioxol-5-yl (hydroxy) methyl) piperidine …
  254. Effects of orlistat, a lipase inhibitor, on the pharmacokinetics of three highly lipophilic drugs (amiodarone, fluoxetine, and simvastatin) in healthy volunteers
  255. Comparative biochemical characterization of the monoacylglycerol lipase inhibitor KML29 in brain, spinal cord, liver, spleen, fat and muscle tissue
  256. Cetilistat (ATL-962), a novel lipase inhibitor: a 12-week randomized, placebo-controlled study of weight reduction in obese patients
  257. Fat intake and food choices during weight reduction with diet, behavioural modification and a lipase inhibitor
  258. Biosynthetic precursors of the lipase inhibitor lipstatin
  259. A simple and effective method based on enzyme-ligand complex for affinity analysis of lipase inhibitor from Schisandra chinensis (Turcz.) Baill
  260. Identification of a new natural gastric lipase inhibitor from star anise
  261. Orlistat, a competitive lipase inhibitor used as an antiobesity remedy, enhances inflammatory reactions in the intestine
  262. Extraction and Characteristics of Anti-obesity Lipase Inhibitor from Phellinus linteus
  263. Extraction and characterization of pectin from apple pomace and its evaluation as lipase (steapsin) inhibitor
  264. Monoacylglycerol lipase inhibitor JZL184 prevents HIV-1 gp120-induced synapse loss by altering endocannabinoid signaling
  265. Effect of the lipase inhibitor orlistat on the pharmacokinetics of four different antihypertensive drugs in healthy volunteers
  266. New insights into weight management by orlistat in comparison with cinnamon as a natural lipase inhibitor
  267. Decreased concentrations of the lipoprotein lipase inhibitor angiopoietin-like protein 4 and increased serum triacylglycerol are associated with increased neonatal fat …
  268. A new method for the measurement of lysosomal acid lipase in dried blood spots using the inhibitor Lalistat 2
  269. The monoacylglycerol lipase inhibitor, JZL184, has comparable effects to therapeutic hypothermia, attenuating global cerebral injury in a rat model of cardiac …
  270. The monoacylglycerol lipase inhibitor JZL184 decreases inflammatory response in skeletal muscle contusion in rats
  271. Crystal structure of a soluble form of human monoglyceride lipase in complex with an inhibitor at 1.35 Å resolution
  272. Therapeutic potential of lipase inhibitor orlistat in Alzheimer’s disease
  273. The inability of a bacterial lipase inhibitor to control acne vulgaris
  274. Influence of a lipase inhibitor on gastric sensitivity and accommodation to an orally ingested meal
  275. A lipase inhibitor monoterpene and monoterpene glycosides from Monarda punctata
  276. Monoacylglycerol lipase inhibitor MJN110 reduces neuronal hyperexcitability, restores dendritic arborization complexity, and regulates reward-related …
  277. Biosynthetic origin of hydrogen atoms in the lipase inhibitor lipstatin
  278. The monoacylglycerol lipase inhibitor KML29 with gabapentin synergistically produces analgesia in mice
  279. Optimal Extraction Conditions of Anti-obesity Lipase Inhibitor from Phellinus linteus and Nutritional Characteristics of the Extracts
  280. Efficacy and safety of lipase inhibitor orlistat in Japanese with excessive visceral fat accumulation: 24-week, double-blind, randomized, placebo-controlled …
  281. The interaction of the lipase inhibitor orlistat with ethanol in healthy volunteers
  282. Familial chylomicronemia due to a circulating inhibitor of lipoprotein lipase activity
  283. Tracer studies with crude U-13C-lipid mixtures: biosynthesis of the lipase inhibitor lipstatin
  284. JZL184, a monoacylglycerol lipase inhibitor, induces bone loss in a multiple myeloma model of immunocompetent mice
  285. Human lysosomal acid lipase inhibitor lalistat impairs Mycobacterium tuberculosis growth by targeting bacterial hydrolases
  286. Reconstruction of evolutionary changes in fat and toxin consumption reveals associations with gene losses in mammals: A case study for the lipase inhibitor PNLIPRP1 and the …
  287. The effects of fatty acid amide hydrolase and monoacylglycerol lipase inhibitor treatments on lipopolysaccharide-induced airway inflammation in mice
  288. Biosynthetic origin of a branched chain analogue of the lipase inhibitor, lipstatin
  289. Potential lipase inhibitor from underutilized part of Andrographis paniculata: Targeted isolation and mechanism of inhibition
  290. Orlistat (Ro 18-0647), a lipase inhibitor, in the treatment of human obesity: a multiple dose study.
  291. Lipase inhibitor orlistat decreases incorporation of eicosapentaenoic and docosahexaenoic acids in rat tissues
  292. JZL184, as a monoacylglycerol lipase inhibitor, down-regulates inflammation in a cannabinoid pathway dependent manner
  293. Evaluation of urinary oxalate levels in patients receiving gastrointestinal lipase inhibitor
  294. Pretreatment with the monoacylglycerol lipase inhibitor URB602 protects from the long-term consequences of neonatal hypoxic–ischemic brain injury in rats
  295. Identification of a novel hormone sensitive lipase inhibitor with a reduced potential of reactive metabolites formation
  296. Effects of a lipase inhibitor (Orlistat) on cholecystokinin and appetite in response to a high-fat meal
  297. Crystal structure of the open form of dog gastric lipase in complex with a phosphonate inhibitor
  298. Identification of bioactive natural products using yeast: Application to monoacylglycerol lipase inhibitor extraction from Corydalis Rhizoma
  299. The crystal structure of a triacylglycerol lipase from Pseudomonas cepacia reveals a highly open conformation in the absence of a bound inhibitor
  300. PPARγ as a sensor of lipase activity and a target for the lipase inhibitor orlistat
  301. Lipase inhibitor orlistat prevents hepatitis B virus infection by targeting an early step in the virus life cycle
  302. Determination of lipase activity in organic solvent using fluorescent substrate and its application to the screening of lipase inhibitor
  303. Effect of the lipase inhibitor orlistat and of dietary lipid on the absorption of radiolabelled triolein, tri-γ-linolenin and tripalmitin in mice
  304. Activity-based protein profiling delivers selective drug candidate ABX-1431, a monoacylglycerol lipase inhibitor, to control lipid metabolism in neurological disorders
  305. Crystallization of a Humicola lanuginosa lipase–inhibitor complex with the use of polyethylene glycol monomethyl ether
  306. Water as a competitive inhibitor of lipase-catalysed esterification in organic media
  307. In vivo characterization of the ultrapotent monoacylglycerol lipase inhibitor {4-[bis-(benzo [d][1, 3] dioxol-5-yl) methyl]-piperidin-1-yl}(1H-1, 2, 4-triazol-1-yl) methanone …
  308. Solvent as a competitive inhibitor for Candida antarctica lipase B
  309. A reversible and selective inhibitor of monoacylglycerol lipase ameliorates multiple sclerosis
  310. Interactions of lipoprotein lipase with the active‐site inhibitor tetrahydrolipstatin (Orlistat)R
  311. Extended use of a selective inhibitor of acid lipase for the diagnosis of Wolman disease and cholesteryl ester storage disease
  312. Orlistat, a gastrointestinal lipase inhibitor, in therapy of obesity with concomitant hyperlipidemia.
  313. Use of an inhibitor to identify members of the hormone-sensitive lipase family
  314. Highly selective, reversible inhibitor identified by comparative chemoproteomics modulates diacylglycerol lipase activity in neurons
  315. The Monoacylglycerol Lipase Inhibitor ABX-1431 Does Not Improve Alcoholic Liver Disease
  316. A gastrointestinal lipase inhibitor reduces progression of atherosclerosis in mice fed a western-type diet
  317. Identification of a novel boronic acid as a potent, selective, and orally active hormone sensitive lipase inhibitor
  318. Poloxamer 407 as a general lipase inhibitor: its implications in lipid metabolism and atheroma formation in C57BL/6 mice
  319. Discovery of XEN445: a potent and selective endothelial lipase inhibitor raises plasma HDL-cholesterol concentration in mice
  320. Dependence of secretory responses to gonadotropin-releasing hormone on diacylglycerol metabolism. Studies with a diacylglycerol lipase inhibitor, RHC 80267.
  321. In Vitro Experimental Assessment of Ethanolic Extract of Moringa oleifera Leaves as an α-Amylase and α-Lipase Inhibitor
  322. Lipase inhibitor orlistat: An old but still effective weapon
  323. The herbicide quinclorac as potent lipase inhibitor: discovery via virtual screening and in vitro/in vivo validation
  324. Characterization of inhibitor protein for lipase in soybean seeds
  325. A proteinaceous competitive inhibitor of lipase isolated from Helianthus annuus seeds
  326. Lipoprotein lipase inhibitor, nordihydroguaiaretic acid, aggravates metabolic phenotypes and alters hdl particle size in the western diet-fed db/db mice
  327. An efficient method based on an inhibitor–enzyme complex to screen an active compound against lipase from Toona sinensis
  328. Monoacylglycerol lipase inhibitor, JZL-184, confers neuroprotection in the mice middle cerebral artery occlusion model of stroke
  329. PK/PD disconnect observed with a reversible endothelial lipase inhibitor
  330. Purification and characterization of proteinaceous inhibitor of lipase from wheat flour
  331. Sesquiterpene farnesol as a competitive inhibitor of lipase activity of Staphylococcus aureus
  332. Best practice in the measurement and interpretation of lysosomal acid lipase in dried blood spots using the inhibitor Lalistat 2
  333. A natural substrate-based fluorescence assay for inhibitor screening on diacylglycerol lipase α
  334. Protective effect of fatty acid amide hydrolase inhibitor URB597 and monoacylglycerol lipase inhibitor KML29 on renal ischemia–reperfusion injury via toll-like receptor …
  335. Kinetics studies of a wheat-derived lipase inhibitor
  336. Lipase activity of guinea pig peritoneal macrophages and mycobacterial lipase inhibitor
  337. Paradoxical effects of JZL184, an inhibitor of monoacylglycerol lipase, on bone remodelling in healthy and cancer-bearing mice
  338. Optimization of a benzoylpiperidine class identifies a highly potent and selective reversible monoacylglycerol lipase (MAGL) inhibitor
  339. … Low Density Lipoprotein Receptor Mediates the Cellular Catabolism of Lipoprotein Lipase and Urokinase-Plasminogen Activator Inhibitor Type I Complexes …
  340. Monoacylglycerol Lipase Inhibitor JJKK048 Ameliorates ABCG2 Transporter-Mediated Regorafenib Resistance Induced by Hypoxia in Triple Negative Breast Cancer …
  341. Refsum’s Disease—Use of the Intestinal Lipase Inhibitor, Orlistat, as a Novel Therapeutic Approach to a Complex Disorder
  342. The effects of the broad-specificity lipase inhibitor, tetrahydrolipstatin, on the growth, development and survival of the larvae of Epiphyas postvittana (Walker) …
  343. Esterastin: a potent inhibitor of lysosomal acid lipase
  344. The effects of systemic and local fatty acid amide hydrolase and monoacylglycerol lipase inhibitor treatments on the metabolomic profile of lungs
  345. Investigation of the Potential Health Benefits as Lipase Inhibitor and Antioxidant of Leopoldia comosa (L.) Parl.: Variability of Chemical Composition of Wild and …
  346. Efficacy, safety and tolerability of orlistat, a lipase inhibitor, in the treatment of adolescent weight excess
  347. Disulfiram is an inhibitor of human purified monoacylglycerol lipase, the enzyme regulating 2‐arachidonoylglycerol signaling
  348. A fluorescence-based assay for monoacylglycerol lipase compatible with inhibitor screening
  349. Inhibition of glucose-induced insulin secretion by the diacylglycerol lipase inhibitor RHC 80267 and the phospholipase A2 inhibitor ACA through stimulation of K+ …
  350. Effect of the diglyceride lipase inhibitor, RG80267, on epithelial chloride secretion induced by various agents
  351. Inhibition of adipose triglyceride lipase (ATGL) by the putative tumor suppressor G0S2 or a small molecule inhibitor attenuates the growth of cancer cells
  352. A novel monoacylglycerol lipase inhibitor with analgesic and anti-inflammatory activity
  353. Wheat flour lipase inhibitor decreases serum lipid levels in male rats
  354. Relationship between a glycoprotein acting as lipoprotein lipase inhibitor and arteriosclerosis
  355. In vitro selection of enzymatically active lipase variants from phage libraries using a mechanism-based inhibitor
  356. Anti-nociceptive potential of an isatin-derived dual fatty acid amide hydrolase-monoacylglycerol lipase inhibitor
  357. Triton WR1339, an inhibitor of lipoprotein lipase, decreases vitamin E concentration in some tissues of rats by inhibiting its transport to liver
  358. Identification of tanshinone IIA as a natural monoacylglycerol lipase inhibitor by combined in silico and in vitro approach
  359. The inhibition of arachidonic acid metabolism in human platelets by RHC 80267, a diacylglycerol lipase inhibitor
  360. Neuroprotective effects of minocycline and KML29, a potent inhibitor of monoacylglycerol lipase, in an experimental stroke model: A small-animal positron …
  361. Preclinical characterization and first-in-human administration of a selective monoacylglycerol lipase inhibitor, ABX-1431
  362. Cilostazol, a selective type III phosphodiesterase inhibitor, decreases triglyceride and increases HDL cholesterol levels by increasing lipoprotein lipase activity in rats
  363. … property and -glucosidase, -amylase and lipase inhibiting activities of Flacourtia inermis fruits: characterization of malic acid as an inhibitor of the enzymes
  364. … of endocannabinoid signaling with JZL184, an inhibitor of the 2-arachidonoylglycerol hydrolyzing enzyme monoacylglycerol lipase, produces anxiolytic effects under …
  365. Non-classical digestive lipase BmTGL selected by gene amplification reduces the effects of mulberry inhibitor during silkworm domestication
  366. Lipase elevation and type 1 diabetes mellitus related to immune checkpoint inhibitor therapy–A multicentre study of 90 patients from the German …
  367. Phenylboronic Acida Potent Inhibitor of Lipase from Oryza sativa
  368. A Proof-of-Concept Inhibitor of Endothelial Lipase Suppresses Triple-Negative Breast Cancer Cells by Hijacking the Mitochondrial Function
  369. … -(4-Fluorophenyl) indol-5-yl]-[3-[4-(thiazole-2-carbonyl) piperazin-1-yl] azetidin-1-yl] methanone, a Reversible, Selective, and Potent Monoacylglycerol Lipase Inhibitor
  370. Selection of orlistat as a potential inhibitor for lipase from Candida species
  371. Lipase inhibitor in Rhizopus microsporus cultures
  372. Acid triacyglycerol lipase inhibitor in chicken plasma: purification and properties.
  373. Inhibition of monoacylglycerol lipase by troglitazone, N‐arachidonoyl dopamine and the irreversible inhibitor JZL184: comparison of two different assays
  374. Lipase Inhibitors from Green Pepper, Capsicum annuun Lin.: I. Separation and Some Properties of Crude Lipase Inhibitor
  375. Design, synthesis, and pharmacological evaluation of a novel series of hormone sensitive lipase inhibitor
  376. Monoacylglycerol lipase inhibitor protects primary cultured neurons against homocysteine-induced impairments in rat caudate nucleus through COX-2 signaling
  377. Discovery of 8-prenylnaringenin from hop (Humulus lupulus L.) as a potent monoacylglycerol lipase inhibitor for treatments of neuroinflammation and …
  378. A serum protein inhibitor of acid lipase and its possible role in lipid accumulation in cultured fibroblasts
  379. Focus on orlistat: a nonsystemic inhibitor of gastrointestinal lipase for weight reduction in the management of obesity
  380. Lipase-triggered drug release from BCL2 inhibitor ABT-199-loaded nanoparticles to elevate anti-leukemic activity through enhanced drug targeting on the …
  381. Inhibition of the effects of thrombin on guinea pig platelets by the diacylglycerol lipase inhibitor RHC 80267
  382. Structure–activity studies in the development of a hydrazone based inhibitor of adipose-triglyceride lipase (ATGL)
  383. Binding of phage displayed Bacillus subtilis lipase A to a phosphonate suicide inhibitor
  384. Inhibition of fatty acid amide hydrolase and monoacylglycerol lipase by the anandamide uptake inhibitor VDM11: evidence that VDM11 acts as an FAAH substrate
  385. Angiopoietin-like protein 4 is a potent hyperlipidemia-inducing factor in mice and inhibitor of lipoprotein lipase
  386. (Z)-Heptadec-8-enylboronic acid: a potential lipase inhibitor
  387. The diacylglycerol lipase inhibitor RHC-80267 potentiates the relaxation to acetylcholine in rat mesenteric artery by anti-cholinesterase action
  388. Two cases with transient lipoprotein lipase (LPL) activity impairment: evidence for the possible involvement of an LPL inhibitor
  389. Production of novel lipase inhibitor from Streptomyces sp
  390. The effects of an inhibitor of diglyceride lipase on collagen-induced platelet activation
  391. Computational analysis and enzyme assay of inhibitor response to disease single nucleotide polymorphisms (SNPs) in lipoprotein lipase
  392. Essential motions in a fungal lipase with bound substrate, covalently attached inhibitor and product
  393. C-terminal domain of apolipoprotein CII as both activator and competitive inhibitor of lipoprotein lipase
  394. Histone deacetylase inhibitor induced lipase inhibitors from endophytic Phomopsis sp. 0391
  395. Parathyroid hormone is not an inhibitor of lipoprotein lipase activity
  396. Monoacylglycerol Lipase Inhibitor Alleviates Pain Transiently Via Peripheral Mechanism And Pain-Induced Depression Long-Term Via Central Mechanism
  397. Orlistat (The Lipase Inhibitor) Therapy in Overweight and Obese Subfertile Women.
  398. Refined homology model of monoacylglycerol lipase: toward a selective inhibitor
  399. The mesophase of parenteral fat emulsion is both substrate and inhibitor of lipoprotein lipase and hepatic lipase
  400. A thiocarbamate inhibitor of endothelial lipase raises HDL cholesterol levels in mice
  401. The activity of hepatic lipase and lipoprotein lipase in glycogen storage disease: evidence for a circulating inhibitor of postheparin lipolytic activity
  402. Identification of ABX-1431, a selective inhibitor of monoacylglycerol lipase and clinical candidate for treatment of neurological disorders
  403. Effect of acarbose, an alpha-glucosidase inhibitor, on serum lipoprotein lipase mass levels and common carotid artery intima-media thickness in type 2 diabetes …
  404. Chitosan dosage regimen to trap fecal oil excretion after peroral lipase inhibitor administration in mice
  405. Mutation of Cys242 of human monoacylglycerol lipase disrupts balanced hydrolysis of 1-and 2-monoacylglycerols and selectively impairs inhibitor potency
  406. Intracellular distribution of lipase in comparison to trypsinogen, amylase and immediately measureable trypsin inhibitor (s) in the rat pancreas
  407. Inhibition of diacylglycerol metabolism in isolated cardiac myocytes by U-57 908 (RHC 80267), a diacylglycerol lipase inhibitor
  408. Adjunction of the lipase inhibitor Orlistat improves grape seed Extract Neuroprotection against Brain Ischemia/Reperfusion Injury in rats
  409. Acid lipase inhibitor in chicken plasma identified as apolipoprotein AI
  410. Intravascular free tissue factor pathway inhibitor is inversely correlated with HDL cholesterol and postheparin lipoprotein lipase but proportional to apolipoprotein A-II
  411. Glucovanillin: A potent inhibitor of lipase from Acinetobacter radioresistens
  412. Enhancement of lipoprotein lipase activity by tissue factor pathway inhibitor
  413. Characteristics of anthocyanins in fortified cakes: a promising potent inhibitor of sucrase, α‐glucosidase and lipase
  414. Angiotensin-converting-enzyme inhibitor administration must be monitored for serum amylase and lipase in order to prevent an acute pancreatitis: a case report
  415. Potency of secondary metabolites in Erythrina subumbrans leaf as lipase inhibitor produced by Propionibacterium acnes
  416. A peptide derived from G0/G1 switch gene 2 acts as noncompetitive inhibitor of adipose triglyceride lipase
  417. Monoacylglycerol lipase inhibitor is safe when combined with delayed r-tPA administration in treatment of stroke
  418. Reduction of excessive visceral fat and safety with 52-week administration of lipase inhibitor orlistat in Japanese: long-term clinical study
  419. Optimization and characterization of a triazole urea inhibitor for diacylglycerol lipase beta (DAGL-β)
  420. Effects of RHC 80267, a diglyceride lipase inhibitor, on prolactin secretion and calcium uptake in GH3 pituitary cells
  421. Activation of lipoprotein lipase and inhibition of B16 melanoma-induced cachexia in mice by ponalrestat, an aldose reductase inhibitor.
  422. A carrier free delivery system of a monoacylglycerol lipase hydrophobic inhibitor
  423. Protein kinase inhibitor blocks the activation of a myocardial triacylglycerol lipase
  424. Lipase-mediated resolution of cis-1-amino-2-indanol, the key component of the HIV protease inhibitor indinavir
  425. Angiopoietin-like protein 4 (ANGPTL4) is an inhibitor of endothelial lipase (EL) while the ANGPTL4/8 complex has reduced EL-inhibitory activity
  426. “Lipolipin”: A Glycoprotein Inhibitor of Postheparin Plasma Lipoprotein Lipase
  427. Study of nicotine acting as an uncompetitive inhibitor of lipase
  428. Stimulation of diuresis and natriuresis by renomedullary infusion of a dual inhibitor of fatty acid amide hydrolase and monoacylglycerol lipase
  429. Use of Lipase Catalytic Resolution in the Preparation of Ethyl (2S,5R)-5-((Benzyloxy)amino)piperidine-2-carboxylate, a Key Intermediate of the β-Lactamase Inhibitor …
  430. Stimulation of inositol phosphate and diacylglycerol production by RHC 80267, a diacylglycerol-lipase inhibitor, in rat gastric parietal cells: effects on hydrogen ion …
  431. … and selective inhibitor of sterol O-acyltransferase 2 markedly reduces hepatic cholesteryl ester accumulation and improves liver function in lysosomal acid lipase …
  432. ISOLATION AND CHARACTERIZATION OF MYCOBACTERIAL LIPASE INHIBITOR FROM CULTURE FILTRATE OF MYCOBACTERIUM TUBER CULOSIS H37Rv
  433. QRLISTAT (THE LIPASE INHIBITOR) THERAPY IN OVERWEIGHT AND OBESE SUB-FERTILE WOMEN
  434. Overexpression of Lipases Enables Specific Cytotoxicity by the Lipase Inhibitor Orlistat in Chronic Lymphocytic Leukemia Cells.
  435. What is the long-term efficacy and tolerability of orlistat, a gastrointestinal lipase inhibitor, for the treatment of obesity in primary care?
  436. … (2R*, 3R*, 4R*)-Dehydroxymethylepoxyquinomycin (DHMEQ), the Precursor for Lipase-Catalyzed Synthesis of the Potent Nuclear Factor-κB Inhibitor,(2S, 3S, 4S) …
  437. Synthesis and Biological Evaluation of Trisubsituted Benzoimidazole as Potential Endothelial Lipase Inhibitor
  438. S‐endo‐2‐Norbornyl‐N‐n‐butylcarbamate as a Potential Pseudomonas Lipase Inhibitor to Probe the Enantioselectivity of the Enzyme by Kinetic and Molecular …
  439. Characterization of lipolytic inhibitor G (0)/G (1) switch gene-2 protein (G0S2) expression in male Sprague-Dawley rat skeletal muscle compared to relative …
  440. Crystallization and preliminary X-ray diffraction studies of a complex of extracellular lipase from Streptomyces rimosus with the inhibitor 3, 4-dichloroisocoumarin
  441. Biomass lipase inhibitor useful for treating adiposity
  442. … Aerosol-OT Aqueous Micelles on the Esterase Activity of Bile-Salt-Stimulated Human-Milk Lipase. Determination of Enzyme-Inhibitor Complex Dissociation Constants
  443. Study on submerged culture conditions of lipase inhibitor producing strain
  444. Familial chylomicronaemia due to a circulating inhibitor of lipoprotein lipase
  445. … text]-glucosidase,[Formula: see text]-amylase and lipase inhibiting activities of Flacourtia inermis fruits: characterization of malic acid as an inhibitor of the enzymes.
  446. A paediatric clinical phenotype variant of lysosomal acid lipase deficiency responsive to an HMG CoA reductase inhibitor (Simvastatin) plus Cholestyramine
  447. Kinetics and Protein‐Inhibitor Docking Studies of Enantiomers of exo‐2‐Norbornyl‐N‐n‐butylcarbamates as Pseudomonas Lipase Inhibitors to Probe the …
  448. Ultrasonic-assistant extraction of lipase inhibitor from Laoshan green tea.
  449. Isolation of a lipase inhibitor from the fungus Rhizopus microsporus
  450. ORLISTAT (LIPASE INHIBITOR) AS AN INEXPENSIVE TEST FOR THE DIAGNOSIS OF CHRONIC PANCREATITIS: A CASE REPORT: 162
  451. Correction: Discovery of 8-prenylnaringenin from hop (Humulus lupulus L.) as a potent monoacylglycerol lipase inhibitor for treatments of neuroinflammation and …
  452. Does the Use of an Oral Lipase Inhibitor (Orlistat) Increase Appetite?
  453. The relationship between dipeptidyl peptidase-4 inhibitor usage and asymptomatic amylase lipase increment in Type 2 diabetes mellitus patients
  454. Mechanism for release of arachidonic acid during guinea pig platelet aggregation: a role for the diacylglycerol lipase inhibitor RHC 80267
  455. Orlistat lipase inhibitor maintains weight loss
  456. Effect of gastrointestinal lipase inhibitor combined with biguanides on serum estrogens in polycystic ovary syndrome with infertility
  457. Lipoprotein lipase inhibitor removal during ultrafiltration of renal failure patients
  458. Immobilization of Lipase Inhibitor on the Biopolymers from Agaricus bisporus Cell Walls
  459. Lysosomal acid lipase inhibitor affects retinyl ester breakdown and hepatic stellate cell activation
  460. Orlistat, an anti‐obesity remedy as a competitive lipase inhibitor, enhanced inflammatory reaction in the intestine
  461. Long-Term Monoacylglycerol Lipase Inhibitor Treatment Decelerates Pathological Changes in APP/PS1-21 Mice, but Behavioral Improvements Require Early …
  462. Effects of RHC-80267, an inhibitor of diacylglycerol lipase, on excitation of circular smooth muscle of the guinea-pig gastric antrum
  463. P18. BEHAVIOURAL STUDY ON NEW MONOACYLGLYCEROL LIPASE INHIBITOR {4-[BIS-(BENZO [D][1, 3] DIOXOL-5-YL) METHYL]-PIPERIDIN-1-YL}(1H-1, 2, 4 …
  464. Computational studies of some benzothiazinone-pepirazine derivatives and lipase b inhibitor for mycobacterium tuberculosis
  465. UC1002, a Carboxyl Ester Lipase Inhibitor, Raises HDL in CETP Transgenic Mice and Increases Reverse Cholesterol Transport, and Also Lowers LDL and VLDL in …
  466. Carrier Free Delivery System of Monoacylglycerol Lipase Hydrophobic Inhibitor for Cancer Therapy
  467. Decreased concentrations of the lipoprotein lipase inhibitor angiopoietin-like protein 4 and increased serum triacylglycerol are associated with increased …
  468. Discovery of 8-prenylnaringenin from hop (Humulus lupulus L.) as a potent monoacylglycerol lipase inhibitor for treatments of neuroinflammation and Alzheimer’s …
  469. Paradoxical effects of JZL184, an inhibitor of monoacylglycerol lipase, on bone remodelling in healthy and cancer-bearing mice
  470. Highly Selective, Reversible Inhibitor Identified by Comparative Chemoproteomics Modulates Diacylglycerol Lipase Activity in Neurons
  471. Glycoprotein Inhibitor of Lipoprotein Lipase from Aortic Intimaā€” Its Possible Role in Atherosclerosis
  472. Protein kinase inhibitor H-7 increases lipoprotein lipase activity in isolated rat fat pads
  473. … PNENYLBORONIC ACID: IN SILICO EVALUATION AS INHIBITOR FOR E. COLI ENZYMES AND IN VITRO TESTS WITH BOVINE ALBUMIN AND YEAST LIPASE
  474. Inside Cover: A Reversible and Selective Inhibitor of Monoacylglycerol Lipase Ameliorates Multiple Sclerosis (Angew. Chem. Int. Ed. 50/2014)
  475. … , $$\boldsymbol {\upalpha} $$-amylase and lipase inhibiting activities of Flacourtia inermis fruits: characterization of malic acid as an inhibitor of the enzymes.
  476. Adrenaline-induced degradation of hepatic lipase in rat hepatocytes is sensitive to the protease inhibitor ALLN.
  477. Complex of tris (2-hydroxyethyl) amine with zinc bis (2-methylphenoxyacetate) as an inhibitor of the acid lipase of the aortic intima
  478. Investigation of the effects of KML29, a selective inhibitor of monoacylglycerol lipase (MAGL) on fever induced by lipopolysaccharide (LPS) in rats
  479. Characteristics of anthocyanins in fortified cake: A possible potent inhibitor of lipase, α-glucosidase and sucrase
  480. … , α $$\boldsymbol {\upalpha} $$-amylase and lipase inhibiting activities of Flacourtia inermis fruits: characterization of malic acid as an inhibitor of the enzymes
  481. Intravascular free tissue factor pathway inhibitor is inversely correlated with HDL cholesterol and postheparin lipoprotein lipase but proportional to …
  482. … P468: Stimulation of Diuresis and Salt Excretion by Renomedullary Infusion of a Dual Inhibitor of Fatty Acid Amide Hydrolase (FAAH) and Monoacylglycerol Lipase  …

Related Posts

Shopping Cart
Scroll to Top